ScoreWhy is Parmax Pharma Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -4.56% and Operating profit at 6.65% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.66
2
Negative results in Sep 25
- NET SALES(9M) At Rs 9.30 cr has Grown at -56.46%
- PAT(9M) At Rs -3.26 cr has Grown at -56.46%
- PBT LESS OI(Q) At Rs -2.09 cr has Fallen at -514.71%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -37.63%, its profits have fallen by -7%
4
Below par performance in long term as well as near term
- Along with generating -37.63% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Parmax Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Parmax Pharma
-35.92%
-0.46
82.52%
Sensex
4.7%
0.40
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.56%
EBIT Growth (5y)
-216.76%
EBIT to Interest (avg)
0.66
Debt to EBITDA (avg)
0.22
Net Debt to Equity (avg)
-2.36
Sales to Capital Employed (avg)
2.35
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-18.25%
ROE (avg)
5.12%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
-2.69
EV to EBIT
-8.05
EV to EBITDA
-10.60
EV to Capital Employed
3.71
EV to Sales
1.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-46.12%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 389.50 times
-18What is not working for the Company
NET SALES(9M)
At Rs 9.30 cr has Grown at -56.46%
PAT(9M)
At Rs -3.26 cr has Grown at -56.46%
PBT LESS OI(Q)
At Rs -2.09 cr has Fallen at -514.71%
PBDIT(Q)
Lowest at Rs -1.59 cr.
EPS(Q)
Lowest at Rs -5.56
Loading Valuation Snapshot...
Here's what is working for Parmax Pharma
Debtors Turnover Ratio- Half Yearly
Highest at 389.50 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Parmax Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -2.09 cr has Fallen at -514.71%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -2.08 cr has Fallen at -845.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Nine Monthly
At Rs 9.30 cr has Grown at -56.46%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -2.09 cr. and Fallen
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Lowest at Rs -2.08 cr. and Fallen
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -1.59 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -5.56
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
